While Moderna has announced it will be making mRNA vaccines on Australian shores by 2024, there are places that could already be doing parts of the process.
One such facility is based in Adelaide, and run by BioCina. BioCina has the technology and regulatory approvals to do microbial cell culture: the first step of the mRNA production process, and is currently using the technology to make other pharmaceutical products.
Cosmos took a look inside the facility to see how this production process might work, and chatted to BioCina’s CEO, Ian Wisenberg.
Curated content from the editorial staff at Cosmos Magazine.
Read science facts, not fiction...
There’s never been a more important time to explain the facts, cherish evidence-based knowledge and to showcase the latest scientific, technological and engineering breakthroughs. Cosmos is published by The Royal Institution of Australia, a charity dedicated to connecting people with the world of science. Financial contributions, however big or small, help us provide access to trusted science information at a time when the world needs it most. Please support us by making a donation or purchasing a subscription today.